Biocon Ltd
NSE:BIOCON

Watchlist Manager
Biocon Ltd Logo
Biocon Ltd
NSE:BIOCON
Watchlist
Price: 335.8 INR 1.28% Market Closed
Market Cap: 403.2B INR
Have any thoughts about
Biocon Ltd?
Write Note

Biocon Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biocon Ltd
Income from Continuing Operations Peer Comparison

Comparables:
524663
526139
Z
532039
HESTERBIO
PANACEABIO

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Biocon Ltd
NSE:BIOCON
Income from Continuing Operations
â‚ą18.7B
CAGR 3-Years
36%
CAGR 5-Years
14%
CAGR 10-Years
15%
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Income from Continuing Operations
-â‚ą184.8m
CAGR 3-Years
-79%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Income from Continuing Operations
-â‚ą3.2m
CAGR 3-Years
69%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Income from Continuing Operations
â‚ą81.4m
CAGR 3-Years
45%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Income from Continuing Operations
â‚ą262.9m
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Panacea Biotec Ltd
NSE:PANACEABIO
Income from Continuing Operations
-â‚ą283.6m
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biocon Ltd's Income from Continuing Operations?
Income from Continuing Operations
18.7B INR

Based on the financial report for Sep 30, 2024, Biocon Ltd's Income from Continuing Operations amounts to 18.7B INR.

What is Biocon Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%

Over the last year, the Income from Continuing Operations growth was 161%. The average annual Income from Continuing Operations growth rates for Biocon Ltd have been 36% over the past three years , 14% over the past five years , and 15% over the past ten years .

Back to Top